Brain, 1460-2156

Journal

More filtering options
  1. 2019
  2. Alzheimer's pathology targets distinct memory networks in the ageing brain

    Maass, A., David Berron, Harrison, T. M., Adams, J. N., La Joie, R., Baker, S., Mellinger, T., Bell, R. K., Swinnerton, K., Inglis, B., Rabinovici, G. D., Düzel, E. & Jagust, W. J., 2019 Aug 1, In : Brain : a journal of neurology. 142, 8, p. 2492-2509 18 p.

    Research output: Contribution to journalArticle

  3. Genome-wide association study of cerebral small vessel disease reveals established and novel loci

    International Stroke Genetics Consortium, Chung, J., Marini, S., Pera, J., Norrving, B., Jimenez-Conde, J., Roquer, J., Fernandez-Cadenas, I., Tirschwell, D. L., Selim, M., Brown, D. L., Silliman, S. L., Worrall, B. B., Meschia, J. F., Demel, S., Greenberg, S. M., Slowik, A., Lindgren, A., Schmidt, R., Traylor, M. & 9 othersSargurupremraj, M., Tiedt, S., Malik, R., Debette, S., Dichgans, M., Langefeld, C. D., Woo, D., Rosand, J. & Anderson, C. D., 2019, In : Brain : a journal of neurology. 142, 10, p. 3176-3189 14 p.

    Research output: Contribution to journalArticle

  4. Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease

    Carl Rosenblad, Li, Q., Pioli, E. Y., Dovero, S., Antunes, A. S. L. M., Agúndez, L., Bardelli, M., Linden, R. M., Henckaerts, E., Anders Björklund, Bezard, E. & Tomas Björklund, 2019, In : Brain : a journal of neurology. p. 2402-2416

    Research output: Contribution to journalArticle

  5. 2018
  6. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency

    Tordo, J., O'Leary, C., Antunes, A. S. L. M., Palomar, N., Aldrin-Kirk, P., Basche, M., Bennett, A., D'Souza, Z., Gleitz, H., Godwin, A., Holley, R. J., Parker, H., Liao, A. Y., Rouse, P., Youshani, A. S., Dridi, L., Martins, C., Levade, T., Stacey, K. B., Davis, D. M. & 11 othersDyer, A., Clément, N., Tomas Björklund, Ali, R. R., Agbandje-McKenna, M., Rahim, A. A., Pshezhetsky, A., Waddington, S. N., Linden, R. M., Bigger, B. W. & Henckaerts, E., 2018 Jul 1, In : Brain. 141, 7, p. 2014-2031 18 p.

    Research output: Contribution to journalArticle

  7. Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?

    Oskar Hansson & Mormino, E. C., 2018 May 1, In : Brain. 141, 5, p. 1241-1244 4 p.

    Research output: Contribution to journalDebate/Note/Editorial

  8. Will FTLD-tau work for all when FTDP-17 retires?

    Emil Ygland, Maria Landqvist Waldö, Elisabet Englund, Andreas Puschmann & Nilsson, C., 2018, In : Brain : a journal of neurology. 141, 8, p. e62

    Research output: Contribution to journalArticle

  9. 2017
  10. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease

    Michael Schöll, Ossenkoppele, R., Olof Strandberg, Sebastian Palmqvist, Jonas Jögi, Ohlsson, T., Ruben Smith, Oskar Hansson & The Swedish BioFINDER study, 2017 Sep 1, In : Brain. 140, 9, p. 2286-2294 9 p.

    Research output: Contribution to journalArticle

  11. Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli

    Tornero, D., Tsupykov, O., Granmo, M., Rodriguez-Fontenla, C., Grønning-Hansen, M., Jonas Thelin, Smozhanik, E., Laterza, C., Wattananit, S., Ge, R., Tatarishvili, J., Shane Grealish, Brüstle, O., Skibo, G., Malin Parmar, Jens Schouenborg, Olle Lindvall & Zaal Kokaia, 2017 Mar 1, In : Brain. 140, 3, p. 692-706 15 p.

    Research output: Contribution to journalArticle

  12. Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism

    Puschmann, A., Fiesel, F. C., Caulfield, T. R., Hudec, R., Ando, M., Truban, D., Hou, X., Ogaki, K., Heckman, M. G., James, E. D., Swanberg, M., Jimenez Ferrer Carrillo, I., Hansson, O., Opala, G., Siuda, J., Boczarska-Jedynak, M., Friedman, A., Koziorowski, D., Aasly, J. O., Lynch, T. & 12 othersMellick, G. D., Mohan, M., Silburn, P. A., Sanotsky, Y., Vilariño-Güell, C., Farrer, M. J., Chen, L., Dawson, V. L., Dawson, T. M., Wszolek, Z. K., Ross, O. A. & Springer, W., 2017 Jan, In : Brain. 140, 1, p. 98-117

    Research output: Contribution to journalArticle

  13. Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke

    Phuah, C-L., Dave, T., Malik, R., Raffeld, M. R., Ayres, A. M., Goldstein, J. N., Viswanathan, A., Greenberg, S. M., Jagiella, J. M., Hansen, B. M., Norrving, B., Jimenez-Conde, J., Roquer, J., Pichler, A., Enzinger, C., Montaner, J., Fernandez-Cadenas, I., Lindgren, A., Slowik, A., Schmidt, R. & 11 othersBiffi, A., Rost, N., Langefeld, C. D., Markus, H. S., Mitchell, B. D., Worrall, B. B., Kittner, S. J., Woo, D., Dichgans, M., Rosand, J. & Anderson, C. D., 2017, In : Brain. 140, 10, p. 2663-2672 10 p.

    Research output: Contribution to journalArticle

  14. Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder

    Puschmann, A., Fiesel, F. C., Caulfield, T. R., Hudec, R., Ando, M., Truban, D., Hou, X., Ogaki, K., Heckman, M. G., James, E. D., Swanberg, M., Jimenez-Ferrer, I., Hansson, O., Opala, G., Siuda, J., Boczarska-Jedynak, M., Friedman, A., Koziorowski, D., Rudzińska-Bar, M., Aasly, J. O. & 13 othersLynch, T., Mellick, G. D., Mohan, M., Silburn, P. A., Sanotsky, Y., Vilarinõ-Güell, C., Farrer, M. J., Chen, L., Dawson, V. L., Dawson, T. M., Wszolek, Z. K., Ross, O. A. & Springer, W., 2017, In : Brain. 140, 6, p. e33

    Research output: Contribution to journalLetter

  15. 2016
  16. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers

    Ruben Smith, Andreas Puschmann, Michael Schöll, Ohlsson, T., Van Swieten, J., Honer, M., Elisabet Englund & Oskar Hansson, 2016 Sep 1, In : Brain. 139, 9, p. 2372-2379 8 p.

    Research output: Contribution to journalArticle

  17. Brain activity and Alzheimer's disease: A complex relationship

    Oskar Hansson & Gunnar Gouras, 2016 Aug 1, In : Brain. 139, 8, p. 2109-2110 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  18. Atomoxetine restores the response inhibition network in Parkinson's disease

    Rae, C. L., Nombela, C., Rodríguez, P. V., Ye, Z., Hughes, L. E., Jones, P. S., Ham, T., Rittman, T., Coyle-Gilchrist, I., Regenthal, R., Sahakian, B. J., Barker, R. A., Robbins, T. W. & Rowe, J. B., 2016 Aug, In : Brain. 139, Pt 8, p. 2235-48 14 p.

    Research output: Contribution to journalArticle

  19. Embodied neurology: an integrative framework for neurological disorders

    Freund, P., Friston, K., Thompson, A. J., Stephan, K. E., Ashburner, J., Bach, D. R., Nagy, Z., Gunther Helms, Draganski, B., Mohammadi, S., Schwab, M. E., Curt, A. & Weiskopf, N., 2016 Jun, In : Brain. 139, p. 1855-1861 7 p.

    Research output: Contribution to journalArticle

  20. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease

    Zhang, J., Rittman, T., Nombela, C., Fois, A., Coyle-Gilchrist, I., Barker, R. A., Hughes, L. E. & Rowe, J. B., 2016 Jan, In : Brain. 139, Pt 1, p. 161-73 13 p.

    Research output: Contribution to journalArticle

  21. NEK1 mutations in familial amyotrophic lateral sclerosis.

    Brenner, D., Müller, K., Wieland, T., Weydt, P., Böhm, S., Lulé, D., Hübers, A., Neuwirth, C., Weber, M., Borck, G., Wahlqvist, M., Danzer, K. M., Volk, A. E., Meitinger, T., Strom, T. M., Otto, M., Kassubek, J., Ludolph, A. C., Andersen, P. M. & Weishaupt, J. H., 2016, In : Brain. 139, 5

    Research output: Contribution to journalLetter

  22. 2015
  23. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study

    Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., Rowe, J. B., Barker, R. A., Burn, D. J. & O'Brien, J. T., 2015 Oct, In : Brain. 138, Pt 10, p. 2974-86 13 p.

    Research output: Contribution to journalArticle

  24. The role of tau in the pathological process and clinical expression of Huntington's disease

    Vuono, R., Winder-Rhodes, S., de Silva, R., Cisbani, G., Drouin-Ouellet, J., Spillantini, M. G., Cicchetti, F., Barker, R. A. & REGISTRY Investigators of the European Huntington’s Disease Network, 2015 Jul, In : Brain. 138, 7, p. 1907-18 12 p.

    Research output: Contribution to journalArticle

  25. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

    Toledo, J. B., Zetterberg, H., van Harten, A. C., Glodzik, L., Martinez-Lage, P., Bocchio-Chiavetto, L., Rami, L., Hansson, O., Sperling, R., Engelborghs, S., Osorio, R. S., Vanderstichele, H., Vandijck, M., Hampel, H., Teipl, S., Moghekar, A., Albert, M., Hu, W. T., Monge Argilés, J. A., Gorostidi, A. & 12 othersTeunissen, C. E., De Deyn, P. P., Hyman, B. T., Molinuevo, J. L., Frisoni, G. B., Linazasoro, G., de Leon, M. J., van der Flier, W. M., Scheltens, P., Blennow, K., Shaw, L. M. & Trojanowski, J. Q., 2015, In : Brain. 138, Jul 27, p. 2701-2715

    Research output: Contribution to journalArticle

  26. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

    Portelius, E., Zetterberg, H., Skillbäck, T., Törnqvist, U., Andreasson, U., Trojanowski, J. Q., Weiner, M. W., Shaw, L. M., Niklas Mattsson & Blennow, K., 2015, In : Brain. 138

    Research output: Contribution to journalArticle

  27. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.

    Skillbäck, T., Farahmand, B. Y., Rosén, C., Mattsson, N., Katarina Nägga, Kilander, L., Religa, D., Wimo, A., Winblad, B., Schott, J. M., Blennow, K., Eriksdotter, M. & Zetterberg, H., 2015, In : Brain. 138, Jun 30, p. 2716-2731

    Research output: Contribution to journalArticle

  28. Cortical burst dynamics predict clinical outcome early in extremely preterm infants.

    Iyer, K. K., Roberts, J. A., Hellström-Westas, L., Wikström, S., Ingrid Pupp, David Ley, Vanhatalo, S. & Breakspear, M., 2015, In : Brain. 138, May 22, p. 2206-2218

    Research output: Contribution to journalArticle

  29. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

    Svenningsson, P., Carl Rosenblad, Af Edholm Arvidsson, K., Wictorin, K., Keywood, C., Shankar, B., Lowe, D. A., Anders Björklund & Håkan Widner, 2015, In : Brain. 138, Feb 10, p. 963-973

    Research output: Contribution to journalArticle

  30. Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's disease.

    Richetin, K., Leclerc, C., Toni, N., Gallopin, T., Pech, S., Laurent Roybon & Rampon, C., 2015, In : Brain. 138, p. 440-455

    Research output: Contribution to journalArticle

  31. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

    Vos, S. J. B., Verhey, F., Frölich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., Rüther, E., Nobili, F., Morbelli, S., Frisoni, G. B., Drzezga, A., Didic, M., van Berckel, B. N. M., Simmons, A., Soininen, H., Kłoszewska, I., Mecocci, P., Tsolaki, M., Vellas, B. & 19 othersLovestone, S., Muscio, C., Herukka, S-K., Salmon, E., Bastin, C., Wallin, A., Nordlund, A., de Mendonça, A., Silva, D., Santana, I., Lemos, R., Engelborghs, S., Van der Mussele, S., Freund-Levi, Y., Åsa Wallin, Hampel, H., van der Flier, W., Scheltens, P. & Visser, P. J., 2015, In : Brain. 138, Feb 17, p. 1327-1338

    Research output: Contribution to journalArticle

  32. 2014
  33. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study

    Nombela, C., Rowe, J. B., Winder-Rhodes, S. E., Hampshire, A., Owen, A. M., Breen, D. P., Duncan, G. W., Khoo, T. K., Yarnall, A. J., Firbank, M. J., Chinnery, P. F., Robbins, T. W., O'Brien, J. T., Brooks, D. J., Burn, D. J., Barker, R. A. & ICICLE-PD Study Group, 2014 Oct, In : Brain. 137, 10, p. 2743-58 16 p.

    Research output: Contribution to journalArticle

  34. Targeting impulsivity in Parkinson's disease using atomoxetine

    Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Müller, U., Rowe, J., Sahakian, B. J. & Robbins, T. W., 2014 Jul, In : Brain. 137, Pt 7, p. 1986-97 12 p.

    Research output: Contribution to journalArticle

  35. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease

    Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., Barker, R. A., Robbins, T. W. & Rowe, J. B., 2014 Apr, In : Brain. 137, Pt 4, p. 1145-55 11 p.

    Research output: Contribution to journalArticle

  36. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

    Hall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G. & Deniz Kirik, 2014, In : Brain. 137, Jul 24, p. 2493-2508

    Research output: Contribution to journalArticle

  37. HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation

    Traeger, U., Andre, R., Lahiri, N., Magnusson-Lind, A., Weiss, A., Grueninger, S., McKinnon, C., Sirinathsinghji, E., Kahlon, S., Pfister, E. L., Moser, R., Hummerich, H., Antoniou, M., Bates, G. P., Luthi-Carter, R., Lowdell, M. W., Maria Björkqvist, Ostroff, G. R., Aronin, N. & Tabrizi, S. J., 2014, In : Brain. 137, p. 819-833

    Research output: Contribution to journalArticle

  38. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.

    Veronica Francardo, Bez, F., Tadeusz Wieloch, Nissbrandt, H., Karsten Ruscher & Angela Cenci Nilsson, 2014, In : Brain. 137, Apr 22, p. 1998-2014

    Research output: Contribution to journalArticle

  39. 2013
  40. Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration

    Xilouri, M., Brekk, O. R., Landeck, N., Pitychoutis, P. M., Papasilekas, T., Papadopoulou-Daifoti, Z., Deniz Kirik & Stefanis, L., 2013, In : Brain. 136, p. 2130-2146

    Research output: Contribution to journalArticle

  41. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery.

    Tornero Prieto, D., Wattananit, S., Grönning Madsen, M., Koch, P., Wood, J., Tatarishvili, J., Mine, Y., Ge, R., Emanuela Monni, Devaraju, K., Hevner, R. F., Brüstle, O., Olle Lindvall & Zaal Kokaia, 2013, In : Brain. 136, 12, p. 3561-3577

    Research output: Contribution to journalArticle

  42. 2012
  43. Hereditary myopathy with early respiratory failure associated with a mutation in A-band titin

    Ohlsson, M., Hedberg, C., Brådvik, B., Lindberg, C., Tajsharghi, H., Danielsson, O., Melberg, A., Udd, B., Martinsson, T. & Oldfors, A., 2012, In : Brain. 135, 6, p. 1682-1694

    Research output: Contribution to journalArticle

  44. 2011
  45. GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.

    Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero-Ramos, M., Deniz Kirik & Anders Björklund, 2011, In : Brain. 134, 8, p. 2302-2311

    Research output: Contribution to journalArticle

  46. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke.

    Karsten Ruscher, Shamloo, M., Rickhag, M., Ladunga, I., Soriano, L., Gisselsson, L., Håkan Toresson, Ruslim-Litrus, L., Oksenberg, D., Urfer, R., Johansson, B., Nikolich, K. & Tadeusz Wieloch, 2011, In : Brain. 134, 3, p. 732-746

    Research output: Contribution to journalArticle

  47. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.

    Ohlin, E., Veronica Francardo, Lindgren, H., Sillivan, S. E., O'Sullivan, S. S., Luksik, A. S., Vassoler, F. M., Lees, A. J., Konradi, C. & Angela Cenci Nilsson, 2011, In : Brain. 134, p. 2339-2357

    Research output: Contribution to journalArticle

  48. 2010
  49. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.

    Woldbye, D. P. D., Ängehagen, M., Gøtzsche, C. R., Elbrønd-Bek, H., Toft Sörensen, A., Christiansen, S. H., Olesen, M. V., Nikitidou, L., Hansen, T. V. O., Kanter Schlifke, I. & Merab Kokaia, 2010, In : Brain. 133, Pt 9, p. 2778-2788

    Research output: Contribution to journalArticle

  50. 2009
  51. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.

    Carlsson, T., Carta, M., Munoz, A., Mattsson, B., Winkler, C., Deniz Kirik & Anders Björklund, 2009, In : Brain. 132, p. 319-335

    Research output: Contribution to journalArticle

  52. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.

    Pouladi, M. A., Graham, R. K., Karasinska, J. M., Xie, Y., Santos, R. D., Åsa Petersén & Hayden, M. R., 2009, In : Brain. 132, p. 919-932

    Research output: Contribution to journalArticle

  53. 2008
  54. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.

    Munoz, A., Li, Q., Gardoni, F., Marcello, E., Qin, C., Carlsson, T., Deniz Kirik, Luca, M. D., Anders Björklund, Bezard, E. & Carta, M., 2008, In : Brain. 131, p. 3380-3394

    Research output: Contribution to journalArticle

  55. Upper limb amputees can be induced to experience a rubber hand as their own

    Ehrsson, H. H., Birgitta Rosén, Stockselius, A., Ragno, C., Kohler, P. & Göran Lundborg, 2008, In : Brain. 131, 12, p. 3443-3452

    Research output: Contribution to journalArticle

  56. 2007
  57. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

    Carta, M., Carlsson, T., Deniz Kirik & Anders Björklund, 2007, In : Brain. 130, 7, p. 1819-1833

    Research output: Contribution to journalArticle

  58. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.

    Eslamboli, A., Romero-Ramos, M., Burger, C., Tomas Björklund, Muzyczka, N., Mandel, R. J., Baker, H., Ridley, R. M. & Deniz Kirik, 2007, In : Brain. 130, 3, p. 799-815

    Research output: Contribution to journalArticle

  59. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis

    Rasmussen, S., Wang, Y., Kivisakk, P., Bronson, R. T., Meyer, M., Imitola, J. & Khoury, S. J., 2007, In : Brain. 130, 11, p. 2816-2829

    Research output: Contribution to journalArticle

Previous 1 2 Next